Get started
Author

Manuel Battegay

Characteristics, Determinants, and Clinical Relevance of CD4 T Cell Recovery to <500 Cells/ L in HIV Type 1--Infected Individuals Receiving Potent Antiretroviral Therapy
2005 · G. R. Kaufmann, H. Furrer, et al. · Clinical Infectious Diseases · 313
PDF
Why is highly active antiretroviral therapy (HAART) not prescribed or discontinued? Swiss HIV Cohort Study.
1999 · S Bassetti, M Battegay, et al. · PubMed · 160
Highly Active Antiretroviral Therapy
2001 · Pedram Sendi, Andrew J. Palmer, et al. · PharmacoEconomics · 142
Lipid Profiles for Antiretroviral-Naive Patients Starting Pi- and Nnrti-Based Therapy in the Swiss HIV Cohort Study
2005 · the Swiss HIV Cohort Study, Jim Young, et al. · Antiviral Therapy · 128
PDF
Highly active antiretroviral therapy during early HIV infection reverses T-cell activation and maturation abnormalities
1998 · Leslie R. Bisset, Richard W. Cone, et al. · AIDS · 99
Effect of Individual Cognitive Behaviour Intervention on Adherence to Antiretroviral Therapy: Prospective Randomized Trial
2004 · the Swiss HIV Cohort Study, Rainer Weber, et al. · Antiviral Therapy · 76
Does Pregnancy Influence the Course of HIV Infection?
1998 · Maja Weisser, Christoph Rudin, et al. · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · 74
Treatment of an atazanivir associated grade 4 hyperbilirubinaemia with efavirenz: Figure 1
2007 · O Kummer, E Mossdorf, et al. · Gut · 65
PDF
Real-world trough concentrations and effectiveness of long-acting cabotegravir and rilpivirine: a multicenter prospective observational study in Switzerland
2023 · Paul Thoueille, Susana Alves Saldanha, et al. · The Lancet Regional Health - Europe · 62
Impact of Integrase Inhibitors on Cardiovascular Disease Events in People With Human Immunodeficiency Virus Starting Antiretroviral Therapy
2023 · Bernard Surial, Frédérique Chammartin, et al. · Clinical Infectious Diseases · 53
PDF
Mycobacterium tuberculosis Transmission in a Country with Low Tuberculosis Incidence: Role of Immigration and HIV Infection
2011 · Lukas Fenner, Sebastien Gagneux, et al. · Journal of Clinical Microbiology · 49
PDF
High Rates of Subsequent Asymptomatic Sexually Transmitted Infections and Risky Sexual Behavior in Patients Initially Presenting With Primary Human Immunodeficiency Virus-1 Infection
2017 · Dominique L Braun, Alex Marzel, et al. · Clinical Infectious Diseases · 46
PDF
Effect of Highly Active Antiretroviral Therapy on Hospitalization Characteristics of HIV-Infected Patients
2002 · Nuesch R., Geigy N., et al. · European Journal of Clinical Microbiology & Infectious Diseases · 46
Increases in Condomless Sex in the Swiss HIV Cohort Study
2015 · R. D. Kouyos, B. Hasse, et al. · Open Forum Infectious Diseases · 39
PDF
High Cure Rates With Grazoprevir-Elbasvir With or Without Ribavirin Guided by Genotypic Resistance Testing Among Human Immunodeficiency Virus/Hepatitis C Virus–coinfected Men Who Have Sex With Men
2018 · Dominique L Braun, Benjamin Hampel, et al. · Clinical Infectious Diseases · 33
PDF
Differences in Virological and Immunological Risk Factors for Non-Hodgkin and Hodgkin Lymphoma
2017 · Leah Shepherd, Lene Ryom, et al. · JNCI Journal of the National Cancer Institute · 27
PDF
Enterococci, Clostridium difficile and ESBL-producing bacteria: epidemiology, clinical impact and prevention in ICU patients
2014 · Jan A. Sidler, Manuel Battegay, et al. · Swiss Medical Weekly · 27
Impact of Genotypic Resistance Testing on Selection of Salvage Regimen in Clinical Practice
2003 · Stefan Haupts, Bruno Ledergerber, et al. · Antiviral Therapy · 26
PDF
Sustained Effect on Hepatitis C Elimination Among Men Who Have Sex With Men in the Swiss HIV Cohort Study: A Systematic Re-Screening for Hepatitis C RNA Two Years Following a Nation-Wide Elimination Program
2022 · Katharina Kusejko, Luisa Salazar-Vizcaya, et al. · Clinical Infectious Diseases · 25
PDF
Antiretroviral Drugs Associated With Subclinical Coronary Artery Disease in the Swiss Human Immunodeficiency Virus Cohort Study
2019 · Helen Kovari, Alexandra Calmy, et al. · Clinical Infectious Diseases · 25
Impact of Direct-Acting Antivirals on the Burden of HCV Infection Among Persons Who Inject Drugs and Men Who Have Sex With Men in the Swiss HIV Cohort Study
2018 · Luisa Salazar-Vizcaya, Gilles Wandeler, et al. · Open Forum Infectious Diseases · 23
PDF
Changing Trends in International Versus Domestic HCV Transmission in HIV-Positive Men Who Have Sex With Men: A Perspective for the Direct-Acting Antiviral Scale-Up Era
2019 · Luisa Salazar-Vizcaya, Roger D Kouyos, et al. · The Journal of Infectious Diseases · 21
PDF
Successful treatment of hepatitis B-associated polyarteritis nodosa with a combination of lamivudine and conventional immunosuppressive therapy: a case report
2000 · D. Maclachlan, M. Battegay, et al. · Lara D. Veeken · 20
Drug Resistance Mutations in HIV-1-Infected Subjects during Protease Inhibitor-Containing Highly Active Antiretroviral Therapy with Nelfinavir or Indinavir
2001 · Sabine Yerly, Martin Rickenbach, et al. · Antiviral Therapy · 19
HIV-1 Low-Level Viremia Predicts Viral Failure in Participants on Antiretroviral Therapy in the Swiss HIV Cohort Study
2024 · Caroline Lanz, Jan Meier, et al. · Clinical Infectious Diseases · 18
Works count: 62
Citation count: 1,795
H-index: 21
I10-index: 32
Year
Topic
Type